These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8776020)

  • 1. Risks and benefits of intravenous immunoglobulin treatment in children.
    Fasano MB
    Curr Opin Pediatr; 1995 Dec; 7(6):688-94. PubMed ID: 8776020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immune globulin use in children. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.
    CMAJ; 1992 Jan; 146(2):121-4. PubMed ID: 1735037
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of intravenous immunoglobulins in pediatric diseases.
    Ramasubramanian KV; Kumar A; Kabra SK; Seth V
    Indian Pediatr; 1999 Jan; 36(1):51-63. PubMed ID: 10709123
    [No Abstract]   [Full Text] [Related]  

  • 4. [Polyvalent immunoglobins in general pediatrics: what place, what risk, and what cost?].
    Dommergues JP; Bader-Meunier B
    Arch Pediatr; 1999; 6 Suppl 2():397s-399s. PubMed ID: 10370548
    [No Abstract]   [Full Text] [Related]  

  • 5. Immune supplementation and immune modulation with intravenous immunoglobulin.
    Mazer BD; Al-Tamemi S; Yu JW; Hamid Q
    J Allergy Clin Immunol; 2005 Oct; 116(4):941-4. PubMed ID: 16210080
    [No Abstract]   [Full Text] [Related]  

  • 6. High dose gammaglobulin treatment for atopic dermatitis.
    Kimata H
    Arch Dis Child; 1994 Apr; 70(4):335-6. PubMed ID: 8185369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reality and clinical application of immunoglobulin preparations].
    Miyara T; Saito A
    Nihon Naika Gakkai Zasshi; 1996 Jun; 85(6):824-8. PubMed ID: 8753046
    [No Abstract]   [Full Text] [Related]  

  • 8. [Is intravenous administration of immunoglobulins a first-choice method in autoimmune diseases?].
    Vermeulen M
    Ned Tijdschr Geneeskd; 1993 Sep; 137(39):1955-8. PubMed ID: 8413702
    [No Abstract]   [Full Text] [Related]  

  • 9. Two episodes of aseptic meningitis during intravenous immunoglobulin therapy of idiopathic thrombocytopenic purpura.
    Mitterer M; Pescosta N; Vogetseder W; Mair M; Coser P
    Ann Hematol; 1993 Sep; 67(3):151-2. PubMed ID: 8373906
    [No Abstract]   [Full Text] [Related]  

  • 10. Intravenous immunoglobulin in oncology nursing practice.
    Timmerman PR
    Oncol Nurs Forum; 1993; 20(1):69-75. PubMed ID: 8421651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulin and autoimmune thrombocytopenic purpura: 22 years on.
    Bierling P; Godeau B
    Vox Sang; 2004 Jan; 86(1):8-14. PubMed ID: 14984554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. You can make a difference in the administration of intravenous immunoglobulin therapy.
    Duff K
    J Infus Nurs; 2006; 29(3 Suppl):S5-14. PubMed ID: 16878850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous immunoglobulin therapy of autoimmune and systemic inflammatory diseases.
    Ronda N; Hurez V; Kazatchkine MD
    Vox Sang; 1993; 64(2):65-72. PubMed ID: 8456559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe dyshidrotic eczema after intravenous immunoglobulin therapy for Kawasaki syndrome.
    Shiraishi T; Yamamoto T
    Pediatr Dermatol; 2013; 30(3):e30-1. PubMed ID: 22304420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulin or megadose methylprednisolone for the treatment of idiopathic thrombocytopenic purpura.
    Ozsoylu S
    Am J Pediatr Hematol Oncol; 1991; 13(3):364-5. PubMed ID: 1817495
    [No Abstract]   [Full Text] [Related]  

  • 16. Adverse reactions after high-dose intravenous immunoglobulin: incidence in 83 patients treated for idiopathic thrombocytopenic purpura (ITP) and review of the literature.
    Schiavotto C; Ruggeri M; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):35-40. PubMed ID: 8039756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute idiopathic thrombocytopenic purpura--management in childhood.
    Bolton-Maggs PH
    Blood; 1997 Feb; 89(4):1465; author reply 1466. PubMed ID: 9028974
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravenous immunoglobulin therapy in autoimmune mucocutaneous blistering diseases: a review of the evidence for its efficacy and safety.
    Gürcan HM; Jeph S; Ahmed AR
    Am J Clin Dermatol; 2010; 11(5):315-26. PubMed ID: 20642294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of a 10% intravenous immunoglobulin preparation in patients with immune thrombocytopenic purpura: results of two international, multicenter studies.
    Kovaleva L; Apte S; Damodar S; Ramanan V; Loriya S; Navarro-Puerto J; Khojasteh A;
    Immunotherapy; 2016 Dec; 8(12):1371-1381. PubMed ID: 27817251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin: new clinical applications.
    Steele RW; Burks AW; Williams LW
    Ann Allergy; 1988 Feb; 60(2):89-94. PubMed ID: 2829663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.